ONIVYDE: payments to doctors
Payments that named ONIVYDE as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $5M
- Providers
- 8,322
- Transactions
- 25,836
- Average per transaction
- $193
The per-transaction average — $193 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 8,322 providers the average total is $599, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | $4,912,576 | 98.5% |
| Ipsen Bioscience Inc | $69,273 | 1.4% |
| Servier Affaires Medicales | $2,983 | 0.1% |
| Epizyme, Inc. | $947 | 0.0% |